View in EDS

Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1.

Saved in:

Bibliographic Details
Title:	Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1.
Authors:	Huang A; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Groer C; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; HylaPharm, LLC, Lawrence, Kansas 66047, United States., Lu R; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Forrest ML; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; HylaPharm, LLC, Lawrence, Kansas 66047, United States., Griffin JD; Kinimmune, Inc., Saint Louis, Missouri 63141, United States., Berkland CJ; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States.; Kinimmune, Inc., Saint Louis, Missouri 63141, United States.
Source:	Molecular pharmaceutics [Mol Pharm] 2022 Nov 07; Vol. 19 (11), pp. 4357-4369. Date of Electronic Publication: 2022 Oct 25.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info:	Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1543-8392
DOI:	10.1021/acs.molpharmaceut.2c00730